vs
Side-by-side financial comparison of Confluent, Inc. (CFLT) and Bio-Techne (TECH). Click either name above to swap in a different company.
Confluent, Inc. is the larger business by last-quarter revenue ($314.8M vs $295.9M, roughly 1.1× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs -25.2%, a 38.0% gap on every dollar of revenue. On growth, Confluent, Inc. posted the faster year-over-year revenue change (20.5% vs -6.4%). Over the past eight quarters, Confluent, Inc.'s revenue compounded faster (20.4% CAGR vs 4.2%).
Confluent, Inc. is an American technology company headquartered in Mountain View, California. Confluent was founded by Jay Kreps, Jun Rao and Neha Narkhede on September 23, 2014, in order to commercialize an open-source streaming platform Apache Kafka, created by the same founders while working at LinkedIn in 2008 as a B2B infrastructure company. Confluent's products are the Confluent Cloud, Confluent Platform, Connectors, Apache Flink, Stream Governance and Confluent Hub.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
CFLT vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $314.8M | $295.9M |
| Net Profit | $-79.2M | $38.0M |
| Gross Margin | 74.7% | 64.6% |
| Operating Margin | -31.5% | 18.4% |
| Net Margin | -25.2% | 12.8% |
| Revenue YoY | 20.5% | -6.4% |
| Net Profit YoY | 10.0% | 68.3% |
| EPS (diluted) | $-0.23 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $314.8M | $295.9M | ||
| Q3 25 | $298.5M | — | ||
| Q2 25 | $282.3M | $317.0M | ||
| Q1 25 | $271.1M | $316.2M | ||
| Q4 24 | $261.2M | $297.0M | ||
| Q3 24 | $250.2M | $289.5M | ||
| Q2 24 | $235.0M | $306.1M | ||
| Q1 24 | $217.2M | $303.4M |
| Q4 25 | $-79.2M | $38.0M | ||
| Q3 25 | $-66.5M | — | ||
| Q2 25 | $-82.0M | $-17.7M | ||
| Q1 25 | $-67.6M | $22.6M | ||
| Q4 24 | $-88.1M | $34.9M | ||
| Q3 24 | $-74.1M | $33.6M | ||
| Q2 24 | $-89.9M | $40.6M | ||
| Q1 24 | $-93.0M | $49.1M |
| Q4 25 | 74.7% | 64.6% | ||
| Q3 25 | 74.2% | — | ||
| Q2 25 | 73.7% | 62.7% | ||
| Q1 25 | 74.5% | 67.9% | ||
| Q4 24 | 74.1% | 65.3% | ||
| Q3 24 | 74.5% | 63.2% | ||
| Q2 24 | 72.3% | 66.4% | ||
| Q1 24 | 71.8% | 67.4% |
| Q4 25 | -31.5% | 18.4% | ||
| Q3 25 | -27.9% | — | ||
| Q2 25 | -34.2% | -7.5% | ||
| Q1 25 | -37.3% | 12.2% | ||
| Q4 24 | -40.5% | 16.0% | ||
| Q3 24 | -37.4% | 13.8% | ||
| Q2 24 | -46.1% | 15.0% | ||
| Q1 24 | -51.3% | 22.1% |
| Q4 25 | -25.2% | 12.8% | ||
| Q3 25 | -22.3% | — | ||
| Q2 25 | -29.0% | -5.6% | ||
| Q1 25 | -24.9% | 7.1% | ||
| Q4 24 | -33.7% | 11.7% | ||
| Q3 24 | -29.6% | 11.6% | ||
| Q2 24 | -38.3% | 13.3% | ||
| Q1 24 | -42.8% | 16.2% |
| Q4 25 | $-0.23 | $0.24 | ||
| Q3 25 | $-0.19 | — | ||
| Q2 25 | $-0.24 | $-0.11 | ||
| Q1 25 | $-0.20 | $0.14 | ||
| Q4 24 | $-0.26 | $0.22 | ||
| Q3 24 | $-0.23 | $0.21 | ||
| Q2 24 | $-0.28 | $0.26 | ||
| Q1 24 | $-0.30 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $347.2M | $172.9M |
| Total DebtLower is stronger | $1.1B | $260.0M |
| Stockholders' EquityBook value | $1.2B | $2.0B |
| Total Assets | $3.0B | $2.5B |
| Debt / EquityLower = less leverage | 0.94× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $347.2M | $172.9M | ||
| Q3 25 | $298.5M | — | ||
| Q2 25 | $295.6M | $162.2M | ||
| Q1 25 | $278.6M | $140.7M | ||
| Q4 24 | $386.0M | $177.5M | ||
| Q3 24 | $322.6M | $187.5M | ||
| Q2 24 | $311.3M | $152.9M | ||
| Q1 24 | $336.4M | $145.3M |
| Q4 25 | $1.1B | $260.0M | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | $346.0M | ||
| Q1 25 | $1.1B | $330.0M | ||
| Q4 24 | $1.1B | $300.0M | ||
| Q3 24 | $1.1B | $300.0M | ||
| Q2 24 | $1.1B | $319.0M | ||
| Q1 24 | $1.1B | $389.0M |
| Q4 25 | $1.2B | $2.0B | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | $1.9B | ||
| Q1 25 | $1.0B | $2.0B | ||
| Q4 24 | $961.2M | $2.1B | ||
| Q3 24 | $934.3M | $2.1B | ||
| Q2 24 | $873.9M | $2.1B | ||
| Q1 24 | $845.2M | $2.0B |
| Q4 25 | $3.0B | $2.5B | ||
| Q3 25 | $2.9B | — | ||
| Q2 25 | $2.8B | $2.6B | ||
| Q1 25 | $2.7B | $2.6B | ||
| Q4 24 | $2.7B | $2.7B | ||
| Q3 24 | $2.6B | $2.7B | ||
| Q2 24 | $2.5B | $2.7B | ||
| Q1 24 | $2.4B | $2.7B |
| Q4 25 | 0.94× | 0.13× | ||
| Q3 25 | 0.98× | — | ||
| Q2 25 | 1.03× | 0.18× | ||
| Q1 25 | 1.07× | 0.16× | ||
| Q4 24 | 1.14× | 0.14× | ||
| Q3 24 | 1.17× | 0.14× | ||
| Q2 24 | 1.25× | 0.15× | ||
| Q1 24 | 1.29× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $42.1M | — |
| Free Cash FlowOCF − Capex | $41.7M | — |
| FCF MarginFCF / Revenue | 13.2% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $60.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $42.1M | — | ||
| Q3 25 | $30.8M | — | ||
| Q2 25 | $18.1M | $98.2M | ||
| Q1 25 | $-26.8M | $41.1M | ||
| Q4 24 | $35.2M | $84.3M | ||
| Q3 24 | $15.6M | $63.9M | ||
| Q2 24 | $8.6M | $75.5M | ||
| Q1 24 | $-26.0M | $81.0M |
| Q4 25 | $41.7M | — | ||
| Q3 25 | $30.0M | — | ||
| Q2 25 | $17.2M | $93.3M | ||
| Q1 25 | $-28.2M | $31.0M | ||
| Q4 24 | $34.5M | $77.5M | ||
| Q3 24 | $15.0M | $54.7M | ||
| Q2 24 | $7.5M | $57.5M | ||
| Q1 24 | $-26.1M | $64.5M |
| Q4 25 | 13.2% | — | ||
| Q3 25 | 10.0% | — | ||
| Q2 25 | 6.1% | 29.4% | ||
| Q1 25 | -10.4% | 9.8% | ||
| Q4 24 | 13.2% | 26.1% | ||
| Q3 24 | 6.0% | 18.9% | ||
| Q2 24 | 3.2% | 18.8% | ||
| Q1 24 | -12.0% | 21.3% |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.3% | 1.5% | ||
| Q1 25 | 0.5% | 3.2% | ||
| Q4 24 | 0.3% | 2.3% | ||
| Q3 24 | 0.2% | 3.2% | ||
| Q2 24 | 0.5% | 5.9% | ||
| Q1 24 | 0.1% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CFLT
| Confluent Cloud | $169.4M | 54% |
| Post Contract Customer Support | $93.8M | 30% |
| License | $38.4M | 12% |
| Services | $13.2M | 4% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
